跳至主要内容
临床试验/NCT01475929
NCT01475929终止2 期

Effect of Probiotic Supplement on Bowel Function

Danisco1 个研究点 分布在 1 个国家目标入组 149 人开始时间: 2011年6月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
终止
发起方
入组人数
149
试验地点
1
主要终点
Change in functional bowel symptoms

研究概览

简要总结

The purpose of this study is to analyse the effect of probiotic supplement on symptoms of irritable bowel syndrome.

详细描述

The aim of the intervention is to analyse the effect of a probiotic supplement in a dose-responsive set up on symptoms of irritable bowel syndrome (IBS). Fulfillment of Rome III criteria will be used as inclusion criterion. Subjective assessment of bowel symptoms, IBS-related quality of life and adequate relief will be assessed as outcome measures.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Subjects aged 18 to 65 with functional bowel symptoms and fulfilling Rome III criteria for IBS will be recruited. Sufficient general health and orientation for participating in the study is required and will be evaluated by the MDs.

排除标准

  • •Diagnosed or suspected organic gastrointestinal diseases or severely impaired general health are exclusion criteria.

研究组 & 干预措施

Probiotic low

Active Comparator

Lower dose of probiotic supplement

干预措施: Probiotic supplement (Dietary Supplement)

Placebo

Placebo Comparator

干预措施: Probiotic supplement (Dietary Supplement)

Probiotic high

Active Comparator

Higher dose of probiotic supplement

干预措施: Probiotic supplement (Dietary Supplement)

结局指标

主要结局

Change in functional bowel symptoms

时间窗: 0 weeks, 6 weeks, 12 weeks

Validated questionnaire

次要结局

  • Adequate relief(Weekly over 3 month intervention)
  • Change in faecal microbiota(0 weeks, 6 weeks, 12 weeks)
  • Change in quality of life(0 weeks, 6 weeks, 12 weeks)

研究者

发起方
Danisco
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验